UniProt ID | PTGR1_HUMAN | |
---|---|---|
UniProt AC | Q14914 | |
Protein Name | Prostaglandin reductase 1 | |
Gene Name | PTGR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 329 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4.. | |
Protein Sequence | MVRTKTWTLKKHFVGYPTNSDFELKTAELPPLKNGEVLLEALFLTVDPYMRVAAKRLKEGDTMMGQQVAKVVESKNVALPKGTIVLASPGWTTHSISDGKDLEKLLTEWPDTIPLSLALGTVGMPGLTAYFGLLEICGVKGGETVMVNAAAGAVGSVVGQIAKLKGCKVVGAVGSDEKVAYLQKLGFDVVFNYKTVESLEETLKKASPDGYDCYFDNVGGEFSNTVIGQMKKFGRIAICGAISTYNRTGPLPPGPPPEIVIYQELRMEAFVVYRWQGDARQKALKDLLKWVLEGKIQYKEYIIEGFENMPAAFMGMLKGDNLGKTIVKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MVRTKTWTLKK ----CCCEEEEEEEE | 22.78 | 25072903 | |
6 | Phosphorylation | --MVRTKTWTLKKHF --CCCEEEEEEEECC | 24.06 | 25072903 | |
8 | Phosphorylation | MVRTKTWTLKKHFVG CCCEEEEEEEECCCC | 33.65 | 25072903 | |
11 | Acetylation | TKTWTLKKHFVGYPT EEEEEEEECCCCCCC | 45.44 | 27452117 | |
11 | Ubiquitination | TKTWTLKKHFVGYPT EEEEEEEECCCCCCC | 45.44 | 29967540 | |
16 | Phosphorylation | LKKHFVGYPTNSDFE EEECCCCCCCCCCCE | 11.11 | 28152594 | |
18 | Phosphorylation | KHFVGYPTNSDFELK ECCCCCCCCCCCEEE | 38.58 | 28258704 | |
20 | Phosphorylation | FVGYPTNSDFELKTA CCCCCCCCCCEEEEC | 46.27 | 28258704 | |
26 | Phosphorylation | NSDFELKTAELPPLK CCCCEEEECCCCCCC | 37.68 | 24275569 | |
55 | Ubiquitination | PYMRVAAKRLKEGDT HHHHHHHHHHHCCCC | 48.83 | 22817900 | |
58 | Ubiquitination | RVAAKRLKEGDTMMG HHHHHHHHCCCCCHH | 64.78 | 21906983 | |
63 | Sulfoxidation | RLKEGDTMMGQQVAK HHHCCCCCHHHHHHH | 3.19 | 30846556 | |
64 | Sulfoxidation | LKEGDTMMGQQVAKV HHCCCCCHHHHHHHH | 4.81 | 30846556 | |
70 | Ubiquitination | MMGQQVAKVVESKNV CHHHHHHHHHHCCCE | 48.21 | 21906983 | |
74 | Phosphorylation | QVAKVVESKNVALPK HHHHHHHCCCEECCC | 20.23 | - | |
75 | Malonylation | VAKVVESKNVALPKG HHHHHHCCCEECCCC | 41.77 | 26320211 | |
75 | 2-Hydroxyisobutyrylation | VAKVVESKNVALPKG HHHHHHCCCEECCCC | 41.77 | - | |
75 | Ubiquitination | VAKVVESKNVALPKG HHHHHHCCCEECCCC | 41.77 | 33845483 | |
81 | Malonylation | SKNVALPKGTIVLAS CCCEECCCCEEEEEC | 70.32 | 26320211 | |
81 | Ubiquitination | SKNVALPKGTIVLAS CCCEECCCCEEEEEC | 70.32 | 22817900 | |
82 | Ubiquitination | KNVALPKGTIVLASP CCEECCCCEEEEECC | 20.80 | 22817900 | |
88 | Phosphorylation | KGTIVLASPGWTTHS CCEEEEECCCCEEEE | 21.56 | 25159151 | |
100 | Acetylation | THSISDGKDLEKLLT EEECCCCHHHHHHHH | 65.22 | 23954790 | |
100 | Ubiquitination | THSISDGKDLEKLLT EEECCCCHHHHHHHH | 65.22 | 29967540 | |
107 | Phosphorylation | KDLEKLLTEWPDTIP HHHHHHHHHCCCCCC | 46.57 | 20068231 | |
168 | Ubiquitination | IAKLKGCKVVGAVGS HHHHCCCEEEEEECC | 48.93 | 33845483 | |
168 | 2-Hydroxyisobutyrylation | IAKLKGCKVVGAVGS HHHHCCCEEEEEECC | 48.93 | - | |
178 | Acetylation | GAVGSDEKVAYLQKL EEECCHHHHHHHHHC | 36.84 | - | |
178 | 2-Hydroxyisobutyrylation | GAVGSDEKVAYLQKL EEECCHHHHHHHHHC | 36.84 | - | |
178 | Ubiquitination | GAVGSDEKVAYLQKL EEECCHHHHHHHHHC | 36.84 | 21906983 | |
184 | Ubiquitination | EKVAYLQKLGFDVVF HHHHHHHHCCCEEEE | 48.24 | 33845483 | |
204 | 2-Hydroxyisobutyrylation | ESLEETLKKASPDGY HHHHHHHHHHCCCCC | 54.43 | - | |
204 | Ubiquitination | ESLEETLKKASPDGY HHHHHHHHHHCCCCC | 54.43 | 22817900 | |
205 | Ubiquitination | SLEETLKKASPDGYD HHHHHHHHHCCCCCC | 58.15 | 22817900 | |
230 | Sulfoxidation | SNTVIGQMKKFGRIA EEEHHHHHHHCCEEE | 4.26 | 30846556 | |
231 | Acetylation | NTVIGQMKKFGRIAI EEHHHHHHHCCEEEE | 36.74 | 19809781 | |
231 | 2-Hydroxyisobutyrylation | NTVIGQMKKFGRIAI EEHHHHHHHCCEEEE | 36.74 | - | |
232 | Acetylation | TVIGQMKKFGRIAIC EHHHHHHHCCEEEEE | 47.94 | 19809789 | |
262 | Phosphorylation | PPPEIVIYQELRMEA CCCCEEEEEEEECEE | 5.76 | 27259358 | |
273 | Phosphorylation | RMEAFVVYRWQGDAR ECEEEEEEECCCHHH | 10.79 | 20068231 | |
280 | Methylation | YRWQGDARQKALKDL EECCCHHHHHHHHHH | 43.18 | 54557191 | |
285 | Malonylation | DARQKALKDLLKWVL HHHHHHHHHHHHHHH | 51.71 | 26320211 | |
289 | Ubiquitination | KALKDLLKWVLEGKI HHHHHHHHHHHHCCC | 42.42 | 29967540 | |
289 | Acetylation | KALKDLLKWVLEGKI HHHHHHHHHHHHCCC | 42.42 | 23954790 | |
324 | Ubiquitination | LKGDNLGKTIVKA-- HCCCCCCCCCCCC-- | 37.94 | 33845483 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTGR1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTGR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTGR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VATA_HUMAN | ATP6V1A | physical | 22939629 | |
ADHX_HUMAN | ADH5 | physical | 26344197 | |
ADK_HUMAN | ADK | physical | 26344197 | |
AK1A1_HUMAN | AKR1A1 | physical | 26344197 | |
ASSY_HUMAN | ASS1 | physical | 26344197 | |
COF1_HUMAN | CFL1 | physical | 26344197 | |
AATC_HUMAN | GOT1 | physical | 26344197 | |
AATM_HUMAN | GOT2 | physical | 26344197 | |
HINT1_HUMAN | HINT1 | physical | 26344197 | |
PRDX6_HUMAN | PRDX6 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...